BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18081652)

  • 1. Review article: Stem cell transplantation for the treatment of gastrointestinal diseases--current applications and future perspectives.
    Al-Toma A; Mulder CJ
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():77-89. PubMed ID: 18081652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases.
    Al-toma A; Nijeboer P; Bouma G; Visser O; Mulder CJ
    World J Gastroenterol; 2014 Dec; 20(46):17368-75. PubMed ID: 25516648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cells therapies for gastrointestinal and liver diseases.
    Iacob R; Sîrbu-Boeţi P; Iacob S; Dima S; Gheorghe C; Gheorghe L; Popescu I
    Chirurgia (Bucur); 2009; 104(2):131-40. PubMed ID: 19499655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
    Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A
    Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haematopoietic SCT in autoimmune diseases in children: rationale and new perspectives.
    Rabusin M; Andolina M; Maximova N;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S96-9. PubMed ID: 18545255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell transplantation for treatment of severe autoimmune diseases: current status and future perspectives.
    Jantunen E; Myllykangas-Luosujärvi R
    Bone Marrow Transplant; 2000 Feb; 25(4):351-6. PubMed ID: 10723576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
    Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding indications for stem cell transplantation.
    Schmit-Pokorny K
    Semin Oncol Nurs; 2009 May; 25(2):105-14. PubMed ID: 19411013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell transplantation (HSCT) for primary systemic vasculitis and related diseases.
    Fiehn C; Ho AD; Lorenz HM
    Autoimmunity; 2008 Dec; 41(8):648-53. PubMed ID: 18958761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematopoietic SCT for children and adolescents with relapsed and refractory Hodgkin's lymphoma.
    Claviez A; Sureda A; Schmitz N
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S16-24. PubMed ID: 18978738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haematopoietic stem cell transplantation for autoimmune disorders: the American perspective.
    Popat U; Krance R
    Br J Haematol; 2004 Sep; 126(5):637-49. PubMed ID: 15327514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
    Toporski J; Garkavij M; Tennvall J; Ora I; Gleisner KS; Dykes JH; Lenhoff S; Juliusson G; Scheding S; Turkiewicz D; Békássy AN
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1077-85. PubMed ID: 19660720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haematopoietic stem cell transplantation for autoimmune disorders.
    Saccardi R; Di Gioia M; Bosi A
    Curr Opin Hematol; 2008 Nov; 15(6):594-600. PubMed ID: 18832930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma.
    Evens AM; Winter JN; Hou N; Nelson BP; Rademaker A; Patton D; Singhal S; Frankfurt O; Tallman MS; Rosen ST; Mehta J; Gordon LI
    Br J Haematol; 2008 Feb; 140(4):385-93. PubMed ID: 18162124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell transplantation for rheumatic autoimmune diseases.
    Hügle T; van Laar JM
    Arthritis Res Ther; 2008; 10(5):217. PubMed ID: 18947373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical care considerations of hematopoietic stem cell transplantation.
    Soubani AO
    Crit Care Med; 2006 Sep; 34(9 Suppl):S251-67. PubMed ID: 16917431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult stem cell transplantation in autoimmune disease.
    Tyndall A; Gratwohl A
    Curr Opin Hematol; 2009 Jul; 16(4):285-91. PubMed ID: 19465851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell transplantation for non-malignant disorders.
    Steward CG
    Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):343-63. PubMed ID: 11030039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.